Found: 58
Select item for more details and to access through your institution.
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
- By:
- Publication type:
- Article
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1105, doi. 10.1093/jjco/hyac110
- By:
- Publication type:
- Article
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer.
- Published in:
- In Vivo, 2021, v. 35, n. 5, p. 2747, doi. 10.21873/invivo.12559
- By:
- Publication type:
- Article
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 1, p. 63, doi. 10.1111/ajco.13050
- By:
- Publication type:
- Article
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
- By:
- Publication type:
- Article
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 7, p. 1154, doi. 10.1007/s10147-022-02162-4
- By:
- Publication type:
- Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
- By:
- Publication type:
- Article
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 10, p. 1835, doi. 10.1007/s10147-020-01721-x
- By:
- Publication type:
- Article
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
- By:
- Publication type:
- Article
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 972, doi. 10.1007/s10147-020-01618-9
- By:
- Publication type:
- Article
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 836, doi. 10.1007/s10147-019-01414-0
- By:
- Publication type:
- Article
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type <italic>RAS</italic> gene: the JACCRO CC-14 study.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 490, doi. 10.1007/s10147-017-1228-5
- By:
- Publication type:
- Article
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 913, doi. 10.1007/s10147-017-1140-z
- By:
- Publication type:
- Article
Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 20, p. 6100, doi. 10.3390/jcm11206100
- By:
- Publication type:
- Article
Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2247, doi. 10.3390/jcm11082247
- By:
- Publication type:
- Article
Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0246160
- By:
- Publication type:
- Article
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18702, doi. 10.1002/cam4.6486
- By:
- Publication type:
- Article
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
- Published in:
- Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
- By:
- Publication type:
- Article
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
- By:
- Publication type:
- Article
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
- By:
- Publication type:
- Article
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234314
- By:
- Publication type:
- Article
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 347, doi. 10.3892/mco.2017.1335
- By:
- Publication type:
- Article
Early Clinical Outcomes of Anal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy with 5-Fluorouracil Plus Mitomycin C in Japanese Patients: Experience at a Single Institution.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 861, doi. 10.1093/jjco/hys093
- By:
- Publication type:
- Article
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 65, doi. 10.1007/s00280-020-04174-1
- By:
- Publication type:
- Article
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 607, doi. 10.1007/s00280-020-04135-8
- By:
- Publication type:
- Article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multicenter phase II study of SOX plus trastuzumab for patients with HER2<sup>+</sup> metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy.
- Published in:
- Case Reports in Oncology, 2017, v. 10, n. 1, p. 81, doi. 10.1159/000455899
- By:
- Publication type:
- Article
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 180, doi. 10.1007/s10120-021-01218-0
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Treatment Strategy for Superficial Pharyngeal Squamous Cell Carcinoma Synchronously Combined with Esophageal Cancer.
- Published in:
- Oncology, 2012, v. 84, n. 1, p. 57, doi. 10.1159/000337981
- By:
- Publication type:
- Article
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
- By:
- Publication type:
- Article
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1125, doi. 10.1002/onco.13816
- By:
- Publication type:
- Article
Phase II Study of Panitumumab Monotherapy in Chemotherapy‐Naïve Frail or Elderly Patients with Unresectable RAS Wild‐Type Colorectal Cancer: OGSG 1602.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 17, doi. 10.1002/ONCO.13523
- By:
- Publication type:
- Article
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
- By:
- Publication type:
- Article